REGENCELL BIOSCIENCE HOLDING (RGC) Stock Price & Overview
NASDAQ:RGC • KYG7487R1002
Current stock price
The current stock price of RGC is 30.8 USD. Today RGC is down by -8.66%. In the past month the price increased by 27.22%. In the past year, price increased by 3533.65%.
RGC Key Statistics
- Market Cap
- 15.23B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
RGC Stock Performance
RGC Stock Chart
RGC Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to RGC. When comparing the yearly performance of all stocks, RGC is one of the better performing stocks in the market, outperforming 99.95% of all stocks.
RGC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RGC. RGC has a great financial health rating, but its profitability evaluates not so good.
RGC Earnings
RGC Forecast & Estimates
RGC Groups
Sector & Classification
RGC Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -54.68% | ||
| ROE | -60.86% | ||
| Debt/Equity | 0 |
RGC Ownership
RGC Latest News, Press Relases and Analysis
RGC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.76 | 882.589B | ||
| JNJ | JOHNSON & JOHNSON | 20.87 | 585.389B | ||
| MRK | MERCK & CO. INC. | 23.36 | 298.838B | ||
| PFE | PFIZER INC | 9.48 | 161.094B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.41 | 121.374B | ||
| ZTS | ZOETIS INC | 16.66 | 49.786B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.4 | 28.018B | ||
| VTRS | VIATRIS INC | 5.36 | 15.475B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.94 | 11.475B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.619B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.372B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.599B | ||
| CORT | CORCEPT THERAPEUTICS INC | 51.43 | 4.52B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RGC
Company Profile
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Company Info
IPO: 2021-07-16
REGENCELL BIOSCIENCE HOLDING
11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
Hong Kong 37918 HK
CEO: Yat-Gai Au
Employees: 12
Phone: 85221550823
REGENCELL BIOSCIENCE HOLDING / RGC FAQ
What does RGC do?
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
What is the current price of RGC stock?
The current stock price of RGC is 30.8 USD. The price decreased by -8.66% in the last trading session.
Does REGENCELL BIOSCIENCE HOLDING pay dividends?
RGC does not pay a dividend.
How is the ChartMill rating for REGENCELL BIOSCIENCE HOLDING?
RGC has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is REGENCELL BIOSCIENCE HOLDING worth?
REGENCELL BIOSCIENCE HOLDING (RGC) has a market capitalization of 15.23B USD. This makes RGC a Large Cap stock.
Who owns REGENCELL BIOSCIENCE HOLDING?
You can find the ownership structure of REGENCELL BIOSCIENCE HOLDING (RGC) on the Ownership tab.
What is the outstanding short interest for REGENCELL BIOSCIENCE HOLDING?
The outstanding short interest for REGENCELL BIOSCIENCE HOLDING (RGC) is 1.07% of its float.